ORIGIN — A Multi-Omics Study of Inflammatory Bowel Disease
ORIGIN · Korean multicentre IBD cohort

Understanding IBD
through the oral–gut axis.

Connecting clinical trajectories with the microbiome, metabolome and diet to investigate Crohn’s disease and ulcerative colitis.

In progress

Current research

Selected projects across microbiome, metabolomics and nutrition.

View all six projects & recent milestones →
Research outputs

Recent publications

The latest publications and accepted work from our investigators.

MORE PUBLICATIONS →
From the research network

News & events

All news →
Work with ORIGIN

Academic & industry collaboration

ORIGIN is the IBD cohort within INTEGRATE, which also includes ankylosing spondylitis and healthy participants. This framework supports investigation of shared and disease-specific oral–gut signatures.

Areas for collaboration

  • Biomarker discovery and independent validation
  • Disease course and treatment-response research
  • Microbiome–metabolome–diet relationships
Meet the Principal Investigator →Email for collaboration →

Collaborative access follows participant consent, ethics approvals and applicable study agreements.

← Back to ORIGIN
The cohort

Following IBD.
Connecting biology
with clinical outcomes.

A nationwide, prospective, multicentre IBD cohort

ORIGIN investigates how the oral and gut microbiome, metabolome, diet and lifestyle relate to inflammatory bowel disease. It brings together people with Crohn’s disease and ulcerative colitis across different stages of disease and treatment, alongside unaffected first-degree relatives.

Longitudinal follow-up and serial biospecimen collection support studies of disease progression, complications and response to biologic and small-molecule therapies. Clinical phenotypes are linked with microbial and metabolic profiles to identify candidate diagnostic, prognostic and treatment-response biomarkers for subsequent validation.

As the core IBD cohort within INTEGRATE, ORIGIN contributes clinically integrated data from an East Asian population. Healthy participants recruited through INTEGRATE provide a complementary reference population using standardized clinical-data and biospecimen-collection procedures.

What does ORIGIN stand for?

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease.

Clinical context

Five predefined participant strata

Complementary populations for studying early disease, established phenotypes, treatment response and familial influences.

Participant stratumDefinition & research context
Inception cohortPatients enrolled within 6 months of diagnosis and followed longitudinally from diagnosis to investigate early disease and subsequent outcomes.
Established IBD cohortPatients with a well-characterized prior clinical course and disease phenotype, supporting investigation of disease heterogeneity and progression.
Advanced-therapy cohortPatients enrolled when initiating a biologic or small-molecule therapy, with longitudinal follow-up of treatment response and subsequent outcomes.
Familial IBD cohortFamilies with at least two affected first-degree relatives, supporting investigation of familial disease patterns.
Unaffected first-degree relativesFirst-degree relatives without IBD, enrolled as family-based controls to help examine genetic and shared environmental influences.
Research approach

Clinical phenotypes, linked across biological layers.

Paired biospecimens and harmonized clinical information connect microbial communities with local and systemic metabolic features.

01 / Biospecimens & clinical data

Following change over time

Saliva, stool and blood samples, with tissue collected in selected participants, are linked to clinical phenotypes, laboratory measurements, medication exposure, disease activity, diet and lifestyle. Serial collections enable longitudinal questions about disease course and treatment.

02 / Microbial & metabolic profiling

Connecting the oral and gut ecosystems

Full-length 16S rRNA gene sequencing and shotgun metagenomics characterize oral and intestinal communities. Metabolomic profiling of saliva, stool and plasma examines their relationship with microbial variation and clinical phenotypes.

03 / Extended analyses & validation

From biological signals to testable markers

Designated subsets support virome, host genomic, transcriptomic, immunological and culturomics analyses. Integrated analyses and machine learning seek candidate biomarkers for independent validation across cohorts and populations.

Analysis platforms, sample availability and follow-up depth vary by participant stratum and designated study subset.

← Back to ORIGIN
Projects & recent milestones

Current research

Ongoing studies and recently accepted work across the ORIGIN and INTEGRATE research programmes.

Project title & focusResearch teamInstitutionStatus

Project overview updated November 2026.

← Back to ORIGIN
Research outputs

Publications

Publications and accepted manuscripts from ORIGIN and its investigators, listed together in reverse chronological order.

This list includes studies using ORIGIN data, earlier studies using independent cohorts, and investigator-led reviews. Each summary describes the relevant study population and scope.

← Back to ORIGIN
COLLABORATORS

A multidisciplinary research network.

Clinical teams and specialists in microbiome science, metabolomics and nutrition working across the ORIGIN cohort.

Gastroenterology

Kangbuk Samsung Hospital

Dong-Il Park, Soo-Kyung Park

Kyungpook National University Hospital

Eun Soo Kim

Kyung Hee University Hospital

Chang Kyun Lee, Ji Eun Kim, Shin-Ju Oh

Keimyung University School of Medicine

Yoo Jin Lee

Dankook University Hospital

Jeong Eun Shin

Daejeon St. Mary’s Hospital · The Catholic University of Korea

Sang-Bum Kang

Soonchunhyang University Cheonan Hospital

Yunho Jung

Yeungnam University Hospital

Kyeong Ok Kim

Wonkwang University Hospital

Geom Seog Seo

Inje University Haeundae Paik Hospital

Tae-Oh Kim

Chonnam National University Hospital

Dong Hyun Kim

Chung-Ang University College of Medicine

Chang Hwan Choi, Seung Yong Shin

Hanyang University Guri Hospital

Chang Soo Eun

Healthy participant research

Kyung Hee University Hospital · Clinical Pharmacology and Therapeutics

Bo-Hyung Kim

Hanyang University Seoul Hospital · Clinical Pharmacology and Therapeutics

Sang Won Lee

Microbiome analysis

Kyung Hee University · Department of Biology

Jin-Woo Bae

Kyung Hee University Hospital · Medical Technology Cooperation Foundation

Hyun Sik Kim

KAIST · InnoCORE AI-CRED Institute

June-Young Lee

Metabolomics

Korea University · Department of Biotechnology

Hong-Seok Son, Juhan Pak, Soobin Bae, Gayoun Lee, Yeongseo Kim

Nutrition

Kyung Hee University · Department of Medical Nutrition & Research Institute of Medical Nutrition

Hyunjung Lim, Inji Lee, Yuna Jung

Sequencing

Macrogen

Macrogen

← Back to ORIGIN
The wider research programme

The INTEGRATE framework

A nationwide prospective observational programme investigating the oral–gut axis in immune-mediated inflammatory diseases.

INTEGRATE connects clinical information with standardized biospecimen collection and multiomics analysis in inflammatory bowel disease (IBD), ankylosing spondylitis (AS) and healthy participants. The design supports comparisons of shared and disease-specific microbial and metabolic features.

ORIGIN is the IBD-focused cohort within this wider framework. Its disease-course and treatment-response studies complement INTEGRATE’s cross-disease and healthy-reference comparisons.

IBD

ORIGIN cohort

Crohn’s disease and ulcerative colitis across five predefined participant strata, including unaffected first-degree relatives.

Explore the ORIGIN cohort →
AS

Ankylosing spondylitis

A complementary IMID population for investigating common and disease-specific oral–gut biological features.

Healthy reference

Healthy participants

Screened healthy individuals recruited using standardized clinical-data and biospecimen procedures.

A common platform for complementary questions

Saliva, stool and blood-derived samples connect oral and intestinal microbial communities with local and systemic metabolic features. Selected subsets support additional host and microbial analyses. ORIGIN supplies longitudinal IBD phenotypes, while the wider programme enables comparisons across diseases and with health.

Published study protocol

Kim HS, Kim BH, Nam B, et al. (2025)

Oral–gut microbiome axis in a Korean cohort with inflammatory bowel disease and ankylosing spondylitis (INTEGRATE): a prospective and observational study protocol

BMJ Open. 2025;15(8):e092075.

The protocol describes the prospective design, participant groups, standardized sampling and integrated oral–gut microbiome and multiomics research strategy.

← Back to ORIGIN
Study leadership

Chang Kyun LeeMD, PhD

Principal Investigator, ORIGIN IBD Cohort
Professor of Medicine, Kyung Hee University College of Medicine
Director, IBD Center, Kyung Hee University Hospital

Chang Kyun Lee, Principal Investigator of the ORIGIN IBD Cohort

Clinical experience informing translational research.

Professor Chang Kyun Lee is a gastroenterologist and physician-scientist specializing in inflammatory bowel disease. His clinical and research work connects the care of patients with Crohn’s disease and ulcerative colitis with studies of the gut and oral microbiome, metabolomics and nutrition.

He leads the ORIGIN IBD cohort and the hospital-based gut microbiome research project at Kyung Hee University Hospital. His research focuses on clinically characterized cohorts, integrated multiomics and the development and validation of candidate biomarkers for diagnosis, disease course and treatment response.

Through ORIGIN and the wider INTEGRATE framework, he welcomes academic and industry collaborations that connect biological discovery with meaningful clinical questions.

Research publications

Publications by year

PubMed-indexed publications attributed to Chang Kyun Lee.

Compiled from PubMed on November 15, 2026, using name variants, author identifiers and affiliation checks. This is a curated snapshot; newly indexed articles may appear later.

Open PubMed author search →
← Back to ORIGIN
From the research network

News & events

Conference presentations, investigator meetings, awards and milestones from the ORIGIN research community.

Contact Professor Lee

Academic and industry collaboration enquiries

Font licenses & credits

This website uses Source Sans 3 by Adobe under the SIL Open Font License, Version 1.1. The original copyright notice and full license text are reproduced below.

Manage publications

Changes are kept in this open page. Download the updated page after saving to keep them.

Manage research

Update a title, team or study status, then download the updated page to keep your changes.

Manage news

Add a conference presentation, research meeting, award or study milestone. Save, then download the updated page to keep your changes.

JPG, PNG or WebP, up to 20 MB. Choose a new file to replace the current image.